Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Reporting to the VP, Finance EMEA, the Senior Manager (SM)/ Associate Director (AD) Accounting will manage the monthly close process and ensure timelines are met. The SM/AD Accounting will serve as the primary coordinator for the monthly close across EMEA entities (CH, IE, DE, and future markets), partnering closely with the global accounting team in alignment with the company close calendar. The SM/AD Accounting will establish and maintain processes to ensure compliance with SOX and external reporting requirements.
The position requires the ability to excel in a rapidly evolving environment, analyze existing processes, and propose and implement improvements. The successful candidate will maintain a positive, collaborative attitude while staying well organized in a fast-paced, high-growth setting.
This role requires strong organization, clear communication, attention to detail, and a strong sense of teamwork, and will help build a critical function at a growing, evolving, multi-product biotechnology company.
Position Responsibilities
- Manage a timely close process for both revenue and OPEX for EMEA entities in line with global accounting processes.
- Implement and maintain robust Gross‑to‑Net (GTN) accounting processes (including rebates, clawbacks, etc.), with reconciliation of related balance sheet accounts.
- Prepare and compile month‑end financial schedules for internal management and external reporting purposes.
- Partner with the Accounts Payable team for EMEA.
- Support the Concur tool for EMEA employees.
- Establish, document, and maintain accounting policies and procedures, including SOX compliance and internal controls.
- Perform detailed account analyses and balance sheet reconciliations.
- Support intercompany financial flows.
- Provide statutory accounting support and coordinate with external firms.
- Serve as the go-to person for RTR and RTP for EMEA.
- Support ad hoc projects as needed (e.g., cash collection, payroll accounting).
Candidate Requirements
- Bachelor’s Degree in Accounting.
- 5–7 years of experience in an accounting role.
- Big 4 experience is a strong plus.
- Strong knowledge of US GAAP and/or IFRS is required.
- ERP (NetSuite, SAP) knowledge is a strong plus.
- Ability to work effectively in a fast-paced environment and manage multiple priorities.
- Ability to work independently and take initiative.
- Strong organization and communication skills are required.
- Strong Excel and general computer skills are required.
- Experience working in a public company is preferred.
- Life sciences industry experience is preferred.
- Fluency in English is required. Additional European languages are an asset.
Skills Required
- Bachelor's degree in Accounting
- 5-7 years of experience in an accounting role
- Strong knowledge of US GAAP and/or IFRS
- Ability to work effectively in a fast-paced environment and manage multiple priorities
- Ability to work independently and take initiative
- Strong organization and communication skills
- Strong Excel and general computer skills
- Fluency in English
- Big 4 experience
- ERP knowledge, including NetSuite or SAP
- Experience working in a public company
- Life sciences industry experience
- Additional European languages
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy
